article thumbnail

Arrhythmias in children undergoing orthotopic heart transplantation

Frontiers in Cardiovascular Medicine

Introduction Heart transplantation (HT) is the only treatment option in children with heart failure secondary to cardiomyopathies and non-reparable congenital heart diseases. 111.87), arrhythmias were detected in 9 (33%) patients. We did not identify significant risk factors for arrhythmias post-HT.

article thumbnail

Heart transplantation for pediatric patients with malignant arrhythmias: Indications and Outcomes

HeartRhythm

Arrhythmias can lead to cardiac arrest (CA) and heart failure. When intractable, heart transplant (HTX) can become the only viable treatment. This rare, high-risk cohort has not been reported as a distinct group.

article thumbnail

PO-03-164 INCIDENCE, PREDICTORS, AND INDICATIONS FOR PERMANENT PACEMAKER IMPLANTATION AFTER ORTHOTOPIC HEART TRANSPLANTATION

HeartRhythm

Cardiac arrhythmias are often encountered in orthotopic heart transplantation (OHT) recipients due to multiple risk factors and may lead to the necessity of permanent pacemaker implantation(PPI). Ischemic time > 4 hours has been associated with graft dysfunction.

article thumbnail

Analysis of survival time in patients receiving cardiac implantable devices after heart transplantation

HeartRhythm

Patients after orthotopic heart transplantation (OHT) are at risk of developing cardiac rhythm disturbances. 1 A rare but significant issue in post-OHT patients is ventricular arrhythmias, in extreme cases leading to cardiac arrest and implantation of an implantable cardioverter-defibrillator (ICD) for secondary prevention.

article thumbnail

A world-class institute dedicated to the treatment of all heart conditions has been inaugurated in Thailand.

Heart 2023 Conference

This institute is dedicated to pioneering research, innovation, and the development of clinically effective techniques for addressing various heart conditions. Additionally, it offers comprehensive cardiac screening and preventive care.

article thumbnail

Effects of atrial fibrillation ablation on arrhythmia burden and ventricular function in end‐stage heart failure: Lessons from CASTLE‐HTx

European Journal of Heart Failure

Abstract Aims The CASTLE-HTx trial showed the benefit of atrial fibrillation (AF) ablation compared to medical therapy in decreasing mortality, need for left ventricular assist device implantation or heart transplantation (HTx) in patients with end-stage heart failure (HF).

article thumbnail

Posttransplant atrial fibrillation: Evidence of early posttransplant recipient?to?donor atrioatrial connections

Journal of Cardiovascular Electrophysiology

Abstract Introduction Atrial fibrillation and atrial flutter originating from the donor s heart is a commonly reported complication post heart transplant. Case A 47-year-old male presented with atrial tachycardia 6 months post heart transplant.